This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

Winners of the Leadership, Education, Advocacy Award announced
NSH
The Leadership, Education, Advocacy Awards are given to individuals and laboratories nominated by their peers that best exemplify the qualities of dedication and service to NSH and recognize demonstrated excellence in the field of histotechnology. Click here for a list of this year's recipients.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




TOP STORIES


New imaging test for multiple sclerosis developed at Case could help speed up new treatments
The Plain Dealer
Multiple sclerosis, an immune-related disease of the brain and spinal cord that causes muscle spasms, numbness and difficulty walking, has no cure. Several treatments can stabilize the disease early in its course or slow it down once it has advanced, but many of them have serious side effects. One of the impediments to advancing research on new treatments for MS is that there is no imaging test that can track or show the exact state of damage to the myelin, which is the fatty protective insulation to the nerves that is broken down during the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Adult cancer patients younger than 50 with limited brain mets have improved SOS after SRS alone
Science Codex
When treated with stereotactic radiosurgery that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented Sept. 23 at the American Society for Radiation Oncology's 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missing immune response may prove a vital link for new leukemia treatments
Medical News Today
Patients suffering from leukemia could have their immune system engineered to fight the disease, after scientists at the University of Birmingham discovered that they lacked an immune response to a certain class of proteins which, could be restored through stem cell transplants.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




New method for analyzing gene expression in single cells opens a window into tumors
Ludwig Institute for Cancer Research via Medical Xpress
A team of researchers affiliated with Ludwig Cancer Research and the Karolinska Institutet in Sweden report in the current issue of Nature Methods a dramatically improved technique for analyzing the genes expressed within a single cell — a capability of relevance to everything from basic research to future cancer diagnostics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword TUMORS.


  PRODUCT SHOWCASES
Spring Bioscience - BRAF V600E


Spring Bioscience is leading the research industry by pioneering novel, next generation antibodies that can differentiate mutant and normal protein, enabling pathologists to see relevant mutations within their cellular context. Having already released Exon19 and EGFR L858R for exclusive use by Ventana Medical Systems, Spring Bioscience has launched BRAF V600E.
Click here to find out more.
ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more
Stellaris RNA FISH Probes


Stellaris RNA FISH is a new research technology that enables direct detection, localization and quantification of RNA. The low cost per assay, simple protocol, and the ability to localize mRNA and lncRNA to organelles and cellular structures provides obvious benefits for life science research. Custom and catalogued probes sets available. MORE


IN THE NEWS


Japanese prime minister funds stem cells to help cure Japan wasting disease
Bloomberg
Economic regeneration is the name of the game for Japanese Prime Minister Shinzo Abe, and cellular regeneration is one way to play it. The government is pushing through bills to fast-track regulatory approval for cell-based products and set new research guidelines. It's also funding a $1.12 billion study of a type of stem cell free from ethical concerns over embryo harvesting that have dogged the science for more than a decade.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Future of cancer treatment or pricey mistake?
CNBC
If you build it, will they pay? Plans to build a $235 million facility in New York City to treat cancer with proton-beam therapy are still proceeding — as are projects for new proton-beam centers around the country — even as some insurers balk at covering the pricier therapy for prostate cancers because of cost-versus-benefit concerns.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Fully Automated RNA-ISH Assays
QuantiGene® ViewRNA RX Assays – designed for use with Leica BOND RX automated IHC and ISH staining platform. Visualize single RNA molecule/cell in FFPE samples. See how.
Produce the best IHC results

Download your IHC application guide and discover reagents to support every stage of your IHC workflow. Visit Abcam at Booth 4 at ECP 2013. DOWNLOAD NOW


Finding the right partner to solve the lyophilization challenge
By Peter Soelkner
About 30 percent of all parenteral drugs approved by the FDA in the past few years involved freeze-dried substances. Experts are predicting a possible rise to even 50 percent in the future. It's definitely a challenge for R&D as well as commercial filling. Therefore, many pharmaceutical and biotech companies rely on outsourcing partners. But how do you find the right partner for the challenge?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Clot busting simulations test potential stroke treatment
R&D Magazine
Researchers are using computer simulations to investigate how ultrasound and tiny bubbles injected into the bloodstream might break up blood clots, limiting the damage caused by a stroke in its first hours. Strokes are the most common cause of long-term disability in the U.S. and the third most common cause of death. More than 795,000 Americans suffer a stroke every year, which happens when a clot blocks an artery or blood vessel and restricts blood flow to the brain.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Intelsint Vacuum Tissue Processors
A line of TPs capable to conveniently cover the needs of every Histology lab. Our attention is focused on reliability, flexibility, ease of usage, samples protection and user safety.

Please visit us at www.intelsint.it
Sakura Smart Automation
Our singular focus is to optimize histology workflow. Rapid tissue-processing, Automated Embedding, and real-time specimen review are just a few of our many innovations.


Study: Mucus protects uterine and pancreatic cancer cells
UPI
A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, U.S. researchers say. Biochemist Daniel Carson, dean of Rice University's Wiess School of Natural Sciences; lead author Neeraja Dharmaraj, a postdoctoral researcher; and graduate student Brian Engel found that protein receptors on the surface of cancer cells go into overdrive to stimulate the production of MUC1, a glycoprotein that forms mucin, or mucus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Specific sugar molecule causes growth of cancer cells
Oncology Nurse Advisor
The process of glycosylation, where sugar molecules are attached to proteins, has long been of interest to scientists, particularly because certain sugar molecules are present in very high numbers in cancer cells. It now turns out that these sugar molecules are not only present in malignant cells but actually aid in their growth. In the long term, this discovery is an important step toward a cure that can stop the growth of cancer cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Patients share DNA for cures (The Wall Street Journal)
New pancreatic stem cell research could transform treatment (CORDIS)
New method to combat antibiotic resistant bacteria (Science World Report)
FDA panel approves drug to shrink breast-cancer tumors presurgery (CBS News)
Microfluidic systems for screening of aptamers (Dr. Afsaneh Motamed-Khorasani)

Don't be left behind. Click here to see what else you missed.


  PRODUCT SHOWCASES
RNAscope: Visualize Single-Copy RNA

RNAscope FFPE Assay Kits make detecting single-copy RNA easy. RNAscope works for virtually any gene in any tissue!

• Exquisite sensitivity & specificity
• Optimized for archival FFPE tissue
• Easy 7-hour IHC-like workflow
• Quantifiable and automatable
• New assays in < 3 weeks
• Guaranteed assay performance
Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.
To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact James DeBois at 469-420-2618

More info
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 25, 2013
Sept. 20, 2013
Sept. 11, 2013
Sept. 4, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063